Copyright 2019 Hubbard Radio Washington DC, LLC. All rights reserved. This website is not intended for users located within the European Economic Area.
VIENNA, Va. (AP) _ Cel-Sci Corp. (CVM) on Monday reported a loss of $9 million in its fiscal second quarter.
The Vienna, Virginia-based company said it had a loss of 25 cents per share. Losses, adjusted for non-recurring costs, came to 17 cents per share.
The cancer immunotherapy company posted revenue of $298,700 in the period. Its adjusted revenue was $299,000.
Cel-Sci shares have risen 59% since the beginning of the year. The stock has increased 84% in the last 12 months.
Insight by LookingGlass: Learn how CTIIC and the Cyber Threat Framework are creating a common lexicon for agencies to understand security threats in this free webinar.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CVM at https://www.zacks.com/ap/CVM
Copyright © 2020 . All rights reserved. This website is not intended for users located within the European Economic Area.